Roche says Tecentriq, chemo cut risk of death in type of lung cancer

ZURICH (Reuters) - Roche said on Tuesday a late-stage study showed the Swiss drugmaker's immunotherapy Tecentriq plus chemotherapy cut the risk of disease worsening or death in first-line treatment of people with a type of advanced lung cancer.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news